Xtant Medical Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 141
Employees
  • Stock Symbol
  • XTNT
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $1.05
  • (As of Thursday Closing)

Xtant Medical General Information

Description

Xtant Medical Holdings Inc mainly develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The company operates through the single segment of Development, manufacture, and marketing of regenerative medical products and devices. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants, and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders and others.

Contact Information

Formerly Known As
Bacterin International
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
ASE
Primary Office
  • 664 Cruiser Lane
  • Belgrade, MT 59714
  • United States
+1 (888) 000-0000

Xtant Medical Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xtant Medical Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.05 $1.02 $0.55 - $3.50 $13.9M 13.2M 699K -$0.61

Xtant Medical Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 88,169 92,744 92,815 145,703
Revenue 57,992 64,682 72,203 82,612
EBITDA 10 792 (53,364) (29,297)
Net Income (8,441) (8,221) (70,099) (52,411)
Total Assets 41,666 43,155 46,422 105,705
Total Debt 79,558 78,540 78,569 138,952
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Xtant Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xtant Medical‘s full profile, request access.

Request a free trial

Xtant Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Xtant Medical Holdings Inc mainly develops, manufactures and markets regenerative medicine products and medical devices
Therapeutic Devices
Belgrade, MT
141 As of 2019
000.00
000000 - 000 000.00

0000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000 0000000 000 00000000
Farmingdale, NY
000 As of 0000
000000000 -

000000 0

m dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
00000000000 0000000
Warsaw, IN
00000 As of 0000
00.000
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xtant Medical Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Misonix Corporation Farmingdale, NY 000 000000000 -
000000 000000 Corporation Warsaw, IN 00000 00.000 000000 - 000 00.000
00000000 Corporation Carlsbad, CA 000 000000 - 000
000000000 Corporation Minneapolis, MN 00000 00000000
0000 0000000 Formerly PE-Backed Harrison, NY 000 0000 00000000 0000
You’re viewing 5 of 12 competitors. Get the full list »

Xtant Medical Executive Team (19)

Name Title Board Seat Contact Info
Darrel Holmes Co-Chief Operating Officer
Kevin Brandt Executive
Molly Mason Vice President, Business Development and Contract Administration
Jimmy Bornheimer Vice President, Finance
Steve Smith Vice President, Regulatory and Quality Assurance
You’re viewing 5 of 19 executive team members. Get the full list »

Xtant Medical Board Members (11)

Name Representing Role Since
0000 00000000 Self Board Member 000 0000
0000 00000000 Self Board Member 000 0000
0000 000000 Self Board Member 000 0000
You’re viewing 3 of 11 board members. Get the full list »

Xtant Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xtant Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xtant Medical‘s full profile, request access.

Request a free trial

Xtant Medical Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0-00000 0000000 31-Jul-2015 000000000000000000 000.00 Therapeutic Devices 000000 0000000000
00000000 0000000 18-Jul-2011 000000000000000000 000 Surgical Devices 000 0000
Ace Oil & Gas 24-Oct-2007 Merger/Acquisition Energy Exploration
To view Xtant Medical’s complete acquisitions history, request access »